Form D · Pharmaceuticals
PINNACLE BIOLOGICS INC
Bannockburn, IL · CIK 0001439099
Offering snapshot reported Dec 29, 2011 · SEC filing
- Reported sold
- $1.5M Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 19, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2011 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Jul 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $150K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-170941
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Healthios Inc. | None | Vector Securities International LLC · CRD 115542 |
Source: Form D, filed Dec 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sandra Chambers | Director |
| James Foght | Director |
| Viren Grover | Director |
| Guillermo Herrera | Director, Executive |
| James Miller | Director |
| Gary C. Parks | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2801 Lakeside Drive Suite 209
Bannockburn, IL, 60015
Bannockburn, IL, 60015